The purpose of FoodSwitch is to bring transparency to the world’s food supply with a vision of an optimised food system for human health and the health of our planet. There are many studies highlighting the link between diet, ill-health and disease. Globally, 1 in 5 deaths are associated with poor diet, with cardiovascular disease being the biggest contributor, followed by cancers and type 2 diabetes. In addition, it is estimated that between 30% and 40% of anthropogenic greenhouse gas emissions (GHGe) are attributable to the global food system. To achieve our purpose, we collect and analyse information from packaged food labels to generate data and insights that can influence government policy and industry practice toward improved food environments. Additionally, we have several apps that allow consumers to make better food choices: Our FoodSwitch App provides simple health and nutrition information on a scanned product and suggests healthier alternatives to 'switch' to, and

Packaged food attribute data The FoodSwitch database holds detailed nutrition and attribute information on individual packaged food products. The data is used for research and advocacy to influence government policy and industry practice toward improved food environments. It is also used by the various apps to help consumers make healthier food choices by offering accessible and clear information about the nutritional content of packaged foods. The database is continually updated, reflecting changes in food formulations and the introduction of new products – it is estimated that there is around 25% - 30% of product churn every 12 months. The data is utilised in various tools and apps to guide users towards healthier eating patterns, supporting public health initiatives and research on dietary habits and nutrition. FoodSwitch: Tracking Food Data Across 17 Jurisdictions AustraliaNew ZealandUnited KingdomSwedenFranceUSAMexicoBrazilChile ChinaFijiHong KongIndiaKuwaitSouth A

Australians consume around 14 teaspoons of added sugar a day - two more than the 12 teaspoons limit recommended by the World Health Organisation (WHO). Eating too many foods high in added sugars can lead to weight gain, an increased risk of obesity related diseases, and is a major risk factor in tooth decay. What is sugar? Sugar is a type of carbohydrate that occurs naturally in foods such as milk and fruit and can also be added to foods and drinks in various forms by the manufacturer or the consumer. Total sugars of a product refers to the combination of sugars that are naturally present and those that are added.Intrinsic and milk sugars occur in foods and drinks such as intact fruits and vegetables (i.e. fructose) and milk (i.e. lactose).Added sugars are all other sugars. It is these sugars that are associated with poor health outcomes and we should avoid. They are often added by manufacturers to give greater sweetness or other desired characteristics. What is added sugar

The 15th World Conference on Injury Prevention and Safety Promotion (Safety 2024) co-sponsored by the World Health Organization will be held between 2nd-4th September 2024 at Taj Palace, New Delhi (India). This event will focus worldwide attention on safety and injury prevention. The event is hosted by The George Institute for Global Health in collaboration with three other WHO Collaborating Centres in the region:  Transportation Research and Injury Prevention Center (TRIP) at the Indian Institute of Technology (IIT) Delhi Department of Emergency Medicine, All India Institute for Medical Sciences (AIIMS) Department of Epidemiology, National Institute of Mental Health and Neuro Sciences (NIMHANS) All the international experts in the field will gather at this event with a united goal of “Building a safer future for all: Equitable and sustainable strategies for injury and violence prevention”. Why is the George Ins

Balancing growth and green At The George Institute, we’re on an exciting journey to make sustainability a core part of everything we do. Our Sustainability Roadmap sets out how we’ll get there. In 2024, we’re laying the groundwork by finalizing our sustainability plan, conducting a thorough audit to understand where we stand, and listening to our stakeholders to learn what matters most to them. In 2025, we’ll start putting our plans into action—introducing initiatives to improve our performance, building better systems for tracking and reporting our progress, and tackling any gaps in the data we need to measure success. By 2026, we’ll focus on refining our processes, ensuring our data is accurate and reliable, and aligning with global frameworks to prepare for external reporting. Finally, in 2027, we’ll bring it all together by fully integrating climate reporting into our annual reporting cycles, ensuring sustainability is firmly embedded in how we work an

Program overview: Health and well-being are intrinsically impacted by socio-determinants related to carers, family, community, and service delivery across health and other sectors, within local country context. Socio-determinants are complex and can include dispossession, institutional racism, drug and alcohol, and debt, resulting in a lack of access to culturally safe services and intergenerational mistrust of services. However, sustainably integrating services within health and other sectors is challenging due to patient, organisational and policy and historical barriers.Our program aims to strengthen health systems resilience using interdisciplinary implementation research across different contexts, cultures and sectors, to holistically address socio-determinants of health so as to improve health equity. Program Objectives:  Examine and implement best practices in community engagement, partnerships and capacity-strengthening.  Embed WHO integrated people-centred

Our multilateral relationships harness the power of combined action, collaborating with others to address the world's leading causes of death and disability. WHO Civil Society CommissionThe George Institute is a member of the WHO Civil Society Commission, a global platform that strengthens dialogue and collaboration between WHO and civil society. Through this Commission, we contribute to a collective effort to provide strategic recommendations that enhance WHO's engagement with civil society at global, regional and national levels. As part of a broader network that includes a Steering Committee, annual General Meetings, and thematic Working Groups, our participation helps advance WHO's mission to achieve health for all, support the objectives of the WHO General Programme of Work, and accelerate progress toward the health‑related Sustainable Development Goals.Learn more WHO Global Clinical Trials ForumThe George Institute is a member of the WHO’s Global Clinical Trials Forum, a glob

We work with civil society groups and networks at local, regional and global levels, sharing evidence and identifying opportunities to influence health-related decisions. Our collective advocacy aims to build momentum and drive changes that reduce inequities and improve the health of millions of people worldwide. Action for Global Health UKLearn moreMore info about Action for Global Health UKAction for Global Health (AfGH) is a network of over 50 organizations working in global health. They connect members with key decision-makers, provide opportunities for joint advocacy and campaigning, and foster a collaborative community to drive progress towards Sustainable Development Goal 3 (Good Health and Well-being).Visit the website UK Working Group on NCDsLearn moreMore info about UK Working Group on NCDsThe UK Working Group on NCDs is a coalition of over 20 UK-based civil society organizations focused on non-communicable diseases (NCDs) as a critical international development issue. Their

What are clinical trials? Clinical trials are research studies with humans, designed to test new treatments to find better ways to prevent, detect or treat disease1. Clinical trials are also sometimes referred to as interventional trials. The sorts of treatments being investigated include medicines or drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, and other items.2 Clinical trials rely on having members of the general public agree to take part. What happens in a clinical trial? In a clinical trial, participants meet with researchers who go through what the clinical trial will involve. All participants must be advised about the objectives of the research, what is expected of them, as well as any risks that may be experienced during and after the trial. Trials must follow a carefully controlled protocol, which is a plan that describes what researchers will do in the stu

The Centre for Operational and Research Excellence (CORE) is a global group and provides high-quality expertise as well as robust operations, systems and processes to deliver The George Institute’s research strategy. CORE’s strategy is to: Achieve and maintain quality and integrity in research Build core skills and capacity in research operations Build and maintain robust systems and processes to enable and support research operations Knowledge management in research operations across The George Institute CORE’s functional activities include: Data Management: DM planning, database build and maintenance, quality data management practices, data cleaning, data sharing processes Project operations: budget development for funding applications, project start-up, implementation and close-out to high quality standards Research strategy and services: funding applications, internal grant programs, research capacity development

Researchers at The George Institute for Global Health, UK, led by Executive Director Professor Otavio Berwanger, are spearheading a programme of work to transform that way we deliver large-scale clinical trials. This programme is borne out of a recognition of the limitations of the ‘traditional’ clinical trial model – and the health gains (social, environmental and economic) – to be had in investigating pragmatic, innovative and efficient approaches. In both the so-called ‘traditional’ and innovative trial models, the gold standard of randomisation controls for both known and unknown confounding factors that could influence trials outcomes, and represents the optimal method to work out whether a healthcare intervention reduces the risk of patient-important outcomes and so inform clinical practice. Where the two models differ is that the traditional approach requires participants be screened and recruited in a trial site by a team of investigators, and so demands both a

Since 2019, the Health 10x Accelerator has supported Australia's brightest health and medtech entrepreneurs in developing affordable and scalable solutions to the world's most pressing unmet health and medical needs. Delivered in partnership with UNSW, the 10-week program provides startups with funding, mentorship, and resources to navigate regulatory pathways, refine investment strategies, and scale globally. Key partners and supporters, including Virtus Health, UNSW Tyree Institute of Health Engineering (IHealthE), Platypus MedTech Consulting, Genesys Electronics Design, Randwick Health & Innovation Precinct, Liverpool Innovation Precinct and AstraZeneca, offer additional support in coaching, investment, and specialised expertise. With the support of our partners and collaborators, startups can gain access to state-of-the-art facilities, collaboration spaces, and commercialisation specialists, enhancing their ability to create impactful solutions that transform global health outc